纹带棒状杆菌的抗菌药敏模式
Antimicrobial susceptibility pattern of Corynebacterium striatum.
作者信息
Martínez-Martínez L, Pascual A, Bernard K, Suárez A I
机构信息
Department of Microbiology, Hospital Universitario Virgen Macarena, Seville, Spain.
出版信息
Antimicrob Agents Chemother. 1996 Nov;40(11):2671-2. doi: 10.1128/AAC.40.11.2671.
Abstract
The in vitro activities of 16 antimicrobial agents against 86 strains of Corynebacterium striatum were evaluated by microdilution using cation-adjusted Mueller-Hinton broth. MICs at which 90% of strains were inhibited were 0.06 microgram/ml for teicoplanin, 1 microgram/ml for vancomycin, 0.03 to 8 micrograms/ml for beta-lactams, 8 micrograms/ml for sparfloxacin, 16 micrograms/ml for ciprofloxacin, 16/304 micrograms/ml for co-trimoxazole (trimethoprim-sulfamethoxazole), 64 micrograms/ml for tetracycline, 128 micrograms/ml for gentamicin, and > 128 micrograms/ml for amikacin, erythromycin, and rifampin.
摘要
采用阳离子调节的 Mueller-Hinton 肉汤，通过微量稀释法评估了 16 种抗菌药物对 86 株纹带棒状杆菌的体外活性。对 90%菌株产生抑制的 MIC 值分别为：替考拉宁 0.06 微克/毫升、万古霉素 1 微克/毫升、β-内酰胺类药物 0.03 至 8 微克/毫升、司帕沙星 8 微克/毫升、环丙沙星 16 微克/毫升、复方新诺明（甲氧苄啶-磺胺甲恶唑）16/304 微克/毫升、四环素 64 微克/毫升、庆大霉素 128 微克/毫升，阿米卡星、红霉素和利福平的 MIC 值均大于 128 微克/毫升。
相似文献
1
Antimicrobial susceptibility pattern of Corynebacterium striatum.纹带棒状杆菌的抗菌药敏模式
Antimicrob Agents Chemother. 1996 Nov;40(11):2671-2. doi: 10.1128/AAC.40.11.2671.
2
In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics.D2群棒状杆菌和杰氏棒状杆菌对十二种抗生素的体外敏感性
Eur J Clin Microbiol Infect Dis. 1990 Dec;9(12):892-5. doi: 10.1007/BF01967505.
3
The susceptibility of isolates of Corynebacterium equi to antimicrobial drugs.马棒状杆菌分离株对抗菌药物的敏感性。
J Vet Pharmacol Ther. 1981 Mar;4(1):27-31. doi: 10.1111/j.1365-2885.1981.tb00706.x.
4
Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin.九种抗菌剂对从临床标本和皮肤分离出的D2群棒状杆菌菌株的活性。
Antimicrob Agents Chemother. 1987 May;31(5):821-2. doi: 10.1128/AAC.31.5.821.
5
Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Corynebacterium jeikeium.杰氏棒状杆菌临床分离株的抗生素敏感性试验（琼脂纸片扩散法和琼脂稀释法）
Chemotherapy. 1998 Jul-Aug;44(4):230-7. doi: 10.1159/000007119.
6
In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.环丙沙星、莫西沙星、万古霉素和红霉素对解脲棒状杆菌浮游菌和生物被膜形式的体外活性。
J Antimicrob Chemother. 2009 Feb;63(2):353-6. doi: 10.1093/jac/dkn491. Epub 2008 Dec 4.
7
Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method.采用美国国家临床实验室标准化委员会（NCCLS）肉汤微量稀释法，比较阳离子调整的穆勒-欣顿肉汤与异感肉汤。
J Antimicrob Chemother. 2000 Sep;46(3):369-76. doi: 10.1093/jac/46.3.369.
8
Antimicrobial susceptibility of Corynebacterium group D2.D2群棒状杆菌的抗菌药敏性
Antimicrob Agents Chemother. 1985 Dec;28(6):845-6. doi: 10.1128/AAC.28.6.845.
9
Teicoplanin combined with various antibiotics and human blood against a multiple-drug-resistant strain of Staphylococcus aureus.替考拉宁与多种抗生素及人血联合对抗耐多药金黄色葡萄球菌菌株。
Chemotherapy. 1991;37(3):186-95. doi: 10.1159/000238852.
10
Clinical relevance and antimicrobial susceptibility profile of the unknown human pathogen .未知人类病原体的临床相关性和抗菌药敏谱。
J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001334. Epub 2021 Mar 18.
引用本文的文献
1
: A True Pathogen in Chronic Contiguous Osteomyelitis.慢性邻接性骨髓炎中的一种真正病原体
Can J Infect Dis Med Microbiol. 2024 Feb 2;2024:5020721. doi: 10.1155/2024/5020721. eCollection 2024.
2
cardiac device-related endocarditis: A case report.心脏装置相关性心内膜炎：一例报告。
IDCases. 2021 Dec 22;27:e01371. doi: 10.1016/j.idcr.2021.e01371. eCollection 2022.
3
The microbiome of the nasopharynx.鼻咽部微生物组。
J Med Microbiol. 2021 Jun;70(6). doi: 10.1099/jmm.0.001368.
4
Clinical characteristics and drug susceptibility patterns of Corynebacterium species in bacteremic patients with hematological disorders.血液系统疾病菌血症患者中棒状杆菌属的临床特征及药敏模式
Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2095-2104. doi: 10.1007/s10096-021-04257-8. Epub 2021 Apr 24.
5
Antimicrobial Resistance and Molecular Epidemiology of Isolated in a Tertiary Hospital in Turkey.土耳其一家三级医院分离菌株的抗菌药物耐药性与分子流行病学
Pathogens. 2020 Feb 19;9(2):136. doi: 10.3390/pathogens9020136.
6
Pyogenic tenosynovitis of the wrist due to Corynebacterium striatum in a patient with dermatomyositis: A case report.皮肌炎患者因纹带棒状杆菌引起的腕部脓性腱鞘炎：一例报告
Medicine (Baltimore). 2020 Jan;99(3):e18761. doi: 10.1097/MD.0000000000018761.
7
Antibiotic Susceptibility Pattern of Non-diphtheriae Corynebacterium Isolates in Ontario, Canada, from 2011 to 2016.2011 年至 2016 年加拿大安大略省非白喉棒状杆菌分离株的抗生素药敏模式。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.01776-17. Print 2018 Apr.
8
Occurrence of Corynebacterium striatum as an emerging antibiotic-resistant nosocomial pathogen in a Tunisian hospital.斯特雷氏棒状杆菌在突尼斯一家医院中作为一种新兴的抗生素耐药性医院病原体的出现。
Sci Rep. 2017 Aug 28;7(1):9704. doi: 10.1038/s41598-017-10081-y.
9
Multidrug-Resistant Corynebacterium striatum Associated with Increased Use of Parenteral Antimicrobial Drugs.多重耐药性纹带棒状杆菌与肠外抗菌药物使用增加相关
Emerg Infect Dis. 2016 Nov;22(11):1908-14. doi: 10.3201/eid2211.160141.
10
Corynebacterium striatum empyema and osteomyelitis in a patient with advanced rheumatoid arthritis.一名晚期类风湿关节炎患者发生纹带棒状杆菌脓胸和骨髓炎。
BMJ Case Rep. 2016 Mar 4;2016:bcr2016214691. doi: 10.1136/bcr-2016-214691.
本文引用的文献
1
Corynebacterium striatum: a diphtheroid with pathogenic potential.纹带棒状杆菌：一种具有致病潜力的类白喉杆菌。
Clin Infect Dis. 1993 Jul;17(1):21-5. doi: 10.1093/clinids/17.1.21.
2
Comparative in vitro activities of new quinolones against coryneform bacteria.新型喹诺酮类药物对棒状杆菌的体外活性比较
Antimicrob Agents Chemother. 1994 Jun;38(6):1439-41. doi: 10.1128/AAC.38.6.1439.
3
Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.棒状杆菌属菌种及其他非芽孢形成革兰氏阳性杆菌对18种抗菌药物的药敏情况
Antimicrob Agents Chemother. 1995 Jan;39(1):208-14. doi: 10.1128/AAC.39.1.208.
4
Comparison of E-test with broth microdilution and disk diffusion for susceptibility testing of coryneform bacteria.E试验与肉汤微量稀释法及纸片扩散法用于棒状杆菌药敏试验的比较。
J Clin Microbiol. 1995 May;33(5):1318-21. doi: 10.1128/jcm.33.5.1318-1321.1995.
5
Phenotypic characteristics of 31 strains of Corynebacterium striatum isolated from clinical samples.从临床样本中分离出的31株纹带棒状杆菌的表型特征。
J Clin Microbiol. 1995 Sep;33(9):2458-61. doi: 10.1128/jcm.33.9.2458-2461.1995.
6
In vitro activity of ciprofloxacin against group JK corynebacteria.环丙沙星对JK群棒状杆菌的体外活性。
Eur J Clin Microbiol. 1984 Aug;3(4):375. doi: 10.1007/BF01977504.
7
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.一种使用显色头孢菌素底物检测β-内酰胺酶的新方法。
Antimicrob Agents Chemother. 1972 Apr;1(4):283-8. doi: 10.1128/AAC.1.4.283.
8
Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid.D2群棒状杆菌尿液分离株对十五种抗菌药物及乙酰氧肟酸的敏感性
J Antimicrob Chemother. 1987 Sep;20(3):349-55. doi: 10.1093/jac/20.3.349.
9
Coryneform bacteria in infectious diseases: clinical and laboratory aspects.感染性疾病中的棒状杆菌：临床与实验室方面
Clin Microbiol Rev. 1990 Jul;3(3):227-46. doi: 10.1128/CMR.3.3.227.
10
In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics.D2群棒状杆菌和杰氏棒状杆菌对十二种抗生素的体外敏感性
Eur J Clin Microbiol Infect Dis. 1990 Dec;9(12):892-5. doi: 10.1007/BF01967505.
Zotero 插件